Molecular Drug Targets in Candida glabrata (original) (raw)

Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting

RSC Advances

Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei

C. Onyewu

Antimicrobial Agents and Chemotherapy, 2003

View PDFchevron_right

Review Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata

Karl Kuchler

2011

View PDFchevron_right

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen

Tahereh Shokohi

View PDFchevron_right

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata

Michael Tscherner

Pharmaceuticals, 2011

View PDFchevron_right

Antifungals: Need to search for a new molecular target

uday deshpande

Indian Journal of Pharmaceutical Sciences, 2008

View PDFchevron_right

Global Clinical Case Studies in Candida species: A Review

Dr. Vijay Karuppiah, Dhandayuthapani Nisha

Asian Journal of Research in Biosciences, 2024

View PDFchevron_right

Glabridin Induces Over-expression of Two Major Apoptotic Genes, MCA1 and NUC1, in Candida albicans

hamed fathi

Journal of global antimicrobial resistance, 2017

View PDFchevron_right

review article antifungal research Strategies aiming for New targets

Frances M Segarra, J. Rodriguez

View PDFchevron_right

Molecular Characterization and In Vitro Antifungal Susceptibility of Candida Glabrata Clinical Isolates with Reduced Echinocandin Susceptibility and High Level Multi-Azole Resistance

Dwayne Baxa

Clinical microbiology, 2014

View PDFchevron_right

Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors

Pooja Jain

Antimicrobial Agents and Chemotherapy, 2003

View PDFchevron_right

Candida glabrata Drug:H + Antiporter CgQdr2 Confers Imidazole Drug Resistance, Being Activated by Transcription Factor CgPdr1

Hiroji Chibana

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

Genomic Identification of Potential Targets Unique to Candida albicans for the Discovery of Antifungal Agents

FEROZ MAZHAR ALEEM KHAN

Current Drug Targets, 2014

View PDFchevron_right

Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans

sankunny M karuppayil

SpringerPlus, 2013

View PDFchevron_right

Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata

Kishore Viswanathan

Journal of Medicinal Chemistry, 2014

View PDFchevron_right

Multiple Drug Targeting Potential of Novel Ligands Against Virulent Proteins of Candida albicans

Anubhuti Jha

International Journal of Peptide Research and Therapeutics, 2019

View PDFchevron_right

The dual role of Candida glabrata drug: H+ antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance

Joana Kátya Sampaio

Frontiers in Microbiology, 2013

View PDFchevron_right

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

Ali Zarei Mahmoudabadi

Current Medical Mycology

View PDFchevron_right

Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

Dario Leonardi

BioMed Research International, 2013

View PDFchevron_right

Probing the Active Site of Candida glabrata Dihydrofolate Reductase with High Resolution Crystal Structures and the Synthesis of New Inhibitors

Dennis Wright

Chemical Biology & Drug Design, 2009

View PDFchevron_right

Tipping the balance both ways: drug resistance and virulence in Candida glabrata

Dominique Sanglard

FEMS Yeast Research, 2015

View PDFchevron_right

Antifungal activity of fibrate-based compounds and substituted pyrroles inhibiting the enzyme 3-hydroxy-methyl-glutaryl-CoA reductase of Candida glabrata (CgHMGR), and decreasing yeast viability and ergosterol synthesis

Carlos Escalante

2021

View PDFchevron_right

Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

Allan Kardec Barros

View PDFchevron_right

Genome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans

John Davison

PLOS Pathogens, 2007

View PDFchevron_right

Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae

Peter Raspor

PeerJ

View PDFchevron_right

Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay

Ursula Bilitewski

Journal of Biotechnology, 2013

View PDFchevron_right

Synergistic and antagonistic effects of immunomodulatory drugs on the action of 1 antifungals against Candida glabrata and Saccharomyces cerevisiae 2 3

Peter Raspor

2018

View PDFchevron_right

Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis

Abdullah ALthubiani

Future Science OA, 2020

View PDFchevron_right

Heterologous expression of full-length lanosterol 14α-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery

Mikhail Keniya

Antimicrobial Agents and Chemotherapy, 2018

View PDFchevron_right

Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents

Lim Vuanghao

PLoS ONE

View PDFchevron_right

Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor

Geoffrey Toner

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

New trends in the search for alternative antifungal therapies

Monika Staniszewska

Pediatria i Medycyna Rodzinna, 2019

View PDFchevron_right

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Ahmed Gamal

Frontiers in Cellular and Infection Microbiology, 2021

View PDFchevron_right

Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata

Michael P. Lombardo

Journal of Medicinal Chemistry, 2014

View PDFchevron_right

Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination

Rodolfo Pinto-Almazán

Pharmaceutics

View PDFchevron_right

Molecular Drug Targets in Candida glabrata (original) (raw)

Related papers